0.5515
price down icon2.32%   -0.0131
after-market 시간 외 거래: .56 0.0085 +1.54%
loading

왜 Scilex Holding Company (SCLX) 주가가 하락하고 있습니까?

2024-11-20 거래 세션 동안 Scilex Holding Company(SCLX) 주식이 13.29% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-09-18:

Scilex Holding Company (SCLX) shares dipped 12.00% to $1.98. Scilex recently announced the completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with acute LBP.

https://www.benzinga.com/news/23/09/34694939/canopy-growth-docgo-and-other-big-stocks-moving-lower-on-monday

2023-04-28:

Scilex Holding Company Stock (SCLX) dropped by 29.3% from $10.27 to $7.26 in the trading on Monday April 28, 2023. The reason why SCLX stock down today is due to stock sale plan and Sorrento bankruptcy update. The company, which is majority owned by Sorrento Therapeutics, said late last week that it planned to sell $300 million worth of stock. On top of that, Sorrento was told by a bankruptcy court in Texas that it had extended the expiration of the restrictions on transfer on the shares of common stock of Scilex that were distributed by Sorrento to its stockholders as a dividend on Jan. 19. The continued uncertainty regarding its parent company and likely dilution of Scilex stock will continue to weigh on the stock.

drug_manufacturers_general BMY
$58.23
price up icon 0.60%
drug_manufacturers_general SNY
$47.98
price up icon 0.42%
drug_manufacturers_general PFE
$25.13
price up icon 0.76%
$289.90
price up icon 0.71%
drug_manufacturers_general NVS
$103.85
price up icon 0.74%
drug_manufacturers_general MRK
$99.86
price up icon 2.48%
자본화:     |  볼륨(24시간):